Although all three ADCs caused complete regression of tumor growth at 3 mg/kg dose, only anti-HER2 HC-A114pAcF ADC showed complete tumor regression at 1 mg/kg in a moues tumor xenografts established from breast cancer cell lines [37,38]. The gene discussed is ERBB2; the disease is breast carcinoma.